Mary Lisa Gavenas
AUTHOR

Mary Lisa Gavenas

Tap the gear icon above to manage new release emails.
For most of my life, my day job was journalism. I was a reporter and editor on daily papers in Virginia and Pennsylvania before moving to New York, where I was a columnist for ELLE, senior editor at GLAMOUR, and department head at INSTYLE and MIRABELLA. Transitioning to business beats, I was an editor at Fairchild, Condé Nast trade division, (WWD/DNR/MENSWEAR) covering post-WTO trade, textiles, trend forecasting, and international luxury retail. Along the way, I freelanced for FAST COMPANY, SALON, HEALTH, THE HOLLYWOOD REPORTER, TRAVEL & LEISURE, and THE NEW YORK TIMES MAGAZINE.

When I write history or biography, I use a history-from-the-ground-up approach that has long been out of fashion. My work relies heavily on first-person narratives and techniques borrowed from sociologists and investigative reporters. My role models are Studs Terkel and the late Mike Wallace, who headed the Gotham Center for New York City, where I was an “expert resource” from 2003–2015. In an age of advocacy history, my work almost always fails to provide neat answers.

My new book, which grew out of my fellowship at the Leon Levy Center for Biography, was called “one of the most anticipated books of 2026” (LIT HUB). Excerpts have run in TOWN & COUNTRY, LIT HUB, and D MAGAZINE. SELLING OPPORTUNITY has been named a NEW YORK TIMES Editors’ Choice, and was reviewed in THE WALL STREET JOURNAL, TEXAS MONTHLY, THE DALLAS MORNING NEWS, HARPER'S, THE NEW YORK POST, and BOOKLIST, and regional publications ranging from THE (WINNIPEG) FREE PRESS to the ARKANSAS DEMOCRAT-GAZETTE. Kirkus put it on the list of “Nonfiction Books That Read Like Novels.”
Read more Read less

Try Audible membership today. Start enjoying the benefits.

Try Audible for free with an audiobook of your choice.
Try Standard free
Auto-renews at AUD $8.99/mo after 30 days. Cancel anytime.

Most Popular

Product list
  • Selling Opportunity cover art
    Preview

    $27.67 or free with 30-day trial